The number of hospitalized COVID-19 patients reached its highest level to date on June 15, when more than 400 patients were hospitalized across Tennessee, according to a report from researchers at Vanderbilt.

Vanderbilt Institute for Global Health (VIGH) has received a new research training grant and a renewal for an existing training program from the Fogarty International Center (FIC) of the National Institutes of Health (NIH) to build HIV-focused research capacity with key partners in Nigeria and Mozambique.

Pregnant women involved in the criminal justice system are disproportionately not receiving medications for opioid use disorder, as compared to their peers, according to a Vanderbilt-led study published today in PLOS Medicine.

Rates of neonatal abstinence syndrome (NAS) have plateaued after 20 years of increasing frequency across the country, according to a new study published in Health Affairs. NAS is a withdrawal syndrome experienced by some opioid-exposed newborns after birth.

After a sharp drop in out-of-pocket costs between 2010 and 2011, Medicare patients who use specialty biologic medications for rheumatoid arthritis have seen higher out-of-pocket spending for those same drugs because of gradual price increases, a new study finds.

A new poll from the Vanderbilt Center for Child Health Policy found that few Tennessee parents take steps to safeguard opioids at home, an important concern when children are spending more time indoors due to COVID-19 social distancing recommendations.

Vanderbilt University Medical Center researchers have found evidence of the rate of COVID-19 infection slowing in Tennessee, which reduces the chance that the state will run out of hospital capacity for patients.